Search clinical trials for: GsI /-

Total 40 results

AbbVie

Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia Areata

United States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom, Korea, Republic of, Chile
AbbVie

Recruiting

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis (UnlIMMited)

Scalp Psoriasis | Genital Psoriasis

United States
CNAO National Center of Oncological Hadrontherapy
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy; Fondazione IRCCS... and other collaborators

Recruiting

Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease (ICONIC)

Melanoma | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma

Italy, Germany
AbbVie

Recruiting

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Hidradenitis Suppurativa

United States, Australia, Canada, Germany, Greece, Japan, Spain, Puerto Rico
NYU Langone Health

Recruiting

Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer

Breast Cancer

United States
University Children's Hospital, Zurich
University Hospital, Geneva; University Children's Hospital Basel

Recruiting

Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies (GSI)

Immunologic Deficiency Syndromes

Switzerland
Eli Lilly and Company
Dermira, Inc.

Active, not recruiting

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) (ADjoin)

Atopic Dermatitis

United States, Spain, Canada, France, Korea, Republic of, Taiwan, Australia, Germany, Bulgaria, Estonia, Latvia, Lithuania, Mexico, Poland, Singapore, Ukraine
Pfizer

Terminated

A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Eczema | Atopic Dermatitis | Eczema, Atopic | Atopic Dermatitis, Unspecified

United States, Canada, Czechia, Poland
AbbVie

Active, not recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up)

Atopic Dermatitis

United States, Australia, Belgium, Bulgaria, Canada, China, Denmark, France, Germany, Hungary, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwa... and more
Botanix Pharmaceuticals

Completed

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) (CARDIGANII)

Axillary Hyperhidrosis

United States
AbbVie

Enrolling by invitation

A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo (Viti-Up)

Vitiligo

United States, Japan, Puerto Rico
AbbVie

Active, not recruiting

Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema) (Measure Up 1)

Atopic Dermatitis

United States, Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Canada, China, Colombia, Croatia, Denmark, Estonia, Finland, France, Germany, Italy, Japan, Malaysia, New Zealand, Puerto Rico, Romania, Russian Federation, Sw... and more
RAPT Therapeutics, Inc.

Suspended

An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Atopic Dermatitis

United States, Canada
Istituto Ortopedico Rizzoli
University of Bologna

Enrolling by invitation

Customized Bone Allografts by 3D-printing (3D-MALF 2)

Musculoskeletal Diseases | Musculoskeletal Disorder | Musculoskeletal Deformity

Italy
Celgene

Active, not recruiting

A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

France, United States, Canada, Spain, Italy
GE Healthcare
University Hospital, Zürich

Completed

Dual Energy Cardiac CT Data Collection and Evaluation

Cardiovascular Diseases

Switzerland
SpringWorks Therapeutics, Inc.

Active, not recruiting

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (DeFi)

Desmoid Tumor | Aggressive Fibromatosis

United States, Belgium, Germany, Canada, Italy, Netherlands, United Kingdom
AbbVie

Completed

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement (IMMprint)

Psoriasis

United States, Canada, Puerto Rico, Spain
Eli Lilly and Company
Dermira, Inc.

Completed

Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere)

Atopic Dermatitis

United States, Canada, Germany, Poland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

Healthy

Japan
King Saud University

Completed

Incentive Spirometer and Inspiratory Muscle Trainer

Parkinson Disease

Saudi Arabia
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network; IPPOX Foundation; EuroVacc Foundation; Global Solutions...

Withdrawn

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

HIV Infections
Stratejik Yenilikci Girisimler Ltd.
The Scientific and Technological Research Council of Turkey; Haseki Training...

Completed

Eustachian Tube Dysfunction Assessment (ETDA)

Eustachian Tube Dysfunction
AbbVie

Completed

A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis

Psoriasis

United States, Puerto Rico
University of Guadalajara

Completed

Effect of Gymnema Sylvestre on Patients With Impaired Glucose Tolerance.

Impaired Glucose Tolerance

Mexico
National Institute of Mental Health (NIMH)

Completed

PET Imaging of Phosphodiesterase-4 (PDE4) in Brain and Peripheral Organs of McCune-Albright Syndrome

Nervous System Disease

United States
TruCare Internal Medicine & Infectious Disease
Gilead Sciences

Completed

Identification to Elimination in HCV-Infected Individuals

Hepatitis C

United States
Beijing Chao Yang Hospital
Peking University People's Hospital; Beijing Friendship Hospital; Peking Union... and other collaborators

Completed

Pursestring Wound Closure vs "Gunsight" Skin Incision and Closure Technique to Reverse Stoma (GSICT1126)

Colostomy

China
Gilead Sciences

Terminated

Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma

Colorectal Cancer

Spain, United States, Germany, Italy, Russian Federation, Poland, France
QOL Medical, LLC

Withdrawn

A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency (GSID-E)

Genetic Sucrase-Isomaltase Deficiency
Centre Hospitalier Universitaire Dijon

Unknown

Epigenetic Integrity of Spermatozoa in Patients With Germinal Testicular Tumours (GAMETH)

Seminomas

France
University Hospital Plymouth NHS Trust

Completed

Cardiac GSI Feasibility Study

High Risk of Significant Coronary Artery Disease

United Kingdom
Gilead Sciences

Completed

A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma

Pancreatic Cancer

United States, Russian Federation
Gilead Sciences

Completed

Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis

Liver Fibrosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating The Coadministration of Begacestat And Donepezil

Healthy Subjects

United States
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population

Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study GSI-136 in Healthy Young and Healthy Elderly Subjects

Healthy | Alzheimer Disease

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males

Healthy | Alzheimer Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

Alzheimer Disease

United States
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML

AML | Elderly

Search clinical trials for: GsI /-

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations